Elutia (ELUT) Cash & Current Investments (2019 - 2026)
Elutia (ELUT) posted Cash & Current Investments of $28.5 million for Q1 2026, down 21.63% sequentially from $36.4 million in Q4 2025, and up 64.12% YoY from $17.4 million in Q1 2025.
Elutia (ELUT) Cash & Current Investments (2019 - 2026) Analysis & Trends
Elutia has reported Cash & Current Investments for 8 years, with the latest figure at $28.5 million in Q1 2026.
- Quarterly Cash & Current Investments rose 64.12% year-over-year to $28.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.5 million (up 64.12% YoY) and the FY2025 annual result came in at $36.4 million, up 174.57% from the prior year.
- Cash & Current Investments retreated to $28.5 million in Q1 2026 per ELUT's latest filing, from $36.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $36.4 million in Q4 2025 and troughed at $4.7 million in Q3 2025.
- A 5-year average of $16.7 million and a median of $16.5 million in 2022 frame the typical range for Cash & Current Investments.
- The widest YoY moves for Cash & Current Investments: up 174.57% in 2025, down 81.66% in 2025.
- Over 5 years, Cash & Current Investments stood at $17.0 million in 2022, then rose by 13.46% to $19.3 million in 2023, then slumped by 31.32% to $13.2 million in 2024, then soared by 174.57% to $36.4 million in 2025, then retreated by 21.63% to $28.5 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $28.5 million, $36.4 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Elutia | 40.75 Mn | 20.85 Mn | 1.45 Mn | 19.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.49 Mn |
| Dec 31, 2025 | 36.35 Mn |
| Sep 30, 2025 | 4.72 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 17.36 Mn |
| Dec 31, 2024 | 13.24 Mn |
| Sep 30, 2024 | 25.74 Mn |
| Jun 30, 2024 | 18.19 Mn |
| Mar 31, 2024 | 12.55 Mn |
| Dec 31, 2023 | 19.28 Mn |
| Sep 30, 2023 | 14.52 Mn |
| Jun 30, 2023 | 9.30 Mn |
| Mar 31, 2023 | 11.79 Mn |
| Dec 31, 2022 | 16.99 Mn |
| Sep 30, 2022 | 8.10 Mn |
| Jun 30, 2022 | 16.51 Mn |
| Mar 31, 2022 | 22.18 Mn |
| Dec 31, 2021 | 30.43 Mn |
| Sep 30, 2021 | 22.63 Mn |
| Jun 30, 2021 | 28.37 Mn |